ARTV Artiva Biotherapeutics, Inc.
$4.27▼ -30.68%
Healthcare
Other
Volume 8.63M
Avg Volume (10D) 483.1K
Key Metrics & Fundamentals
Market Cap
$208.76M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.96 - 14.53
% vs 50 MA
-50.05%
% vs 200 MA
-46.85%
RSI-14
20.9
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.77
Free Cash Flow
-$20.77M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$26.20M
COGS
–
Operating Exp
$26.89M
Operating Income
-$26.89M
EBIT
-$26.89M
Pretax Income
-$25.01M
Net Income
-$25.01M
EPS (Diluted)
-0.63
Price & Volume History
Loading chart…
Recent News
Sector Update: Healthcare Stocks Decline Late Afternoon
MT Newswires · Oct 27, 2026 3:51 PM ET
Artiva Biotherapeutics Shares Fall After Announcing Plan to End AlloNK Development, Analyst Downgrades
MT Newswires · Oct 27, 2026 2:51 PM ET
Top Midday Decliners
MT Newswires · Oct 27, 2026 2:12 PM ET
Artiva Biotherapeutics Plunges Into Crisis Over Patient Deaths and Possible Liquidation
Benzinga · Oct 27, 2026 1:58 PM ET
Why Is Artiva Biotherapeutics Discontinuing AlloNK Development and Cutting 94% of Its Workforce?
InvestorsHub · Oct 27, 2026 12:22 PM ET
Artiva to quit autoimmune cell therapy work, cut staff after patient deaths
BioPharma Dive · Oct 27, 2026 11:44 AM ET
Needham Downgrades Artiva Biotherapeutics to Hold From Buy
MT Newswires · Oct 27, 2026 10:44 AM ET
Artiva Scraps Development Of Lead Drug Candidate After Patient Deaths — ARTV Stock Heads For Worst Session In Over 18 Months
Stocktwits · Oct 27, 2026 10:08 AM ET
Wedbush Downgrades Artiva Biotherapeutics to Neutral From Outperform, Cuts Price Target to $4 From $40
MT Newswires · Oct 27, 2026 10:07 AM ET
Artiva Biotherapeutics stock tumbles after halting drug trial
Investing.com · Oct 27, 2026 8:40 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ARTV's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.